✦ LIBER ✦

Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients

✍ Scribed by Jacot, William; Pujol, Jean-Louis; Chakra, Mohammad; Molinier, Olivier; Bozonnat, Marie-Cécile; Gervais, Radj; Quantin, Xavier

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide/Vindesine chemotherapy in pri

✍ H. Höfeler; B. Schoetensack; J. Kemper; G. Krüger; U. Wandl; J. Schütte; N. Nied 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 131 KB

Second-line chemotherapy in relapsing or

✍ Georgoulias, Vassilis A 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A phase II study of sunitinib in patient

✍ Han, Ji-Youn; Kim, Hyae Young; Lim, Kun Young; Han, Jong Hee; Lee, You Jin; Kwak 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Phase II Trial of Gemcitabine/Irinotecan

✍ Wolfgang Schuette; Sylke Nagel; Stefan Juergens; Ines Bork; Bettina Wollschlaege 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 508 KB

Phase II study of irinotecan and carbopl

✍ Hirose, Takashi; Horichi, Naoya; Ohmori, Tohru; Ogura, Keiichi; Hosaka, Takamich 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Phase II trial of amrubicin and carbopla

✍ Hirose, Takashi; Nakashima, Masanao; Shirai, Takao; Kusumoto, Sojiro; Sugiyama, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB